Patterns of lymphotropic herpesvirus viraemia in HIV-infected patients with Kaposi's sarcoma treated with highly active antiretroviral therapy and liposomal daunorubicin

被引：7
|
作者：
Torre-Cisneros, J [1 ]
Pozo, F
Serrano, R
Vidal, E
Rivero, A
Tenorio, A
机构：
[1] Univ Cordoba, Hosp Reina Sofia, Infect Dis Sect, E-14004 Cordoba, Spain
[2] Inst Salud Carlos III, Ctr Nacl Microbiol, Serv Diagnost Microbiol, E-28220 Madrid, Spain
来源：
AIDS | 2000年 / 14卷 / 14期
关键词：
D O I：
10.1097/00002030-200009290-00026
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：2215 / 2217
页数：3
相关论文
共 50 条
  • [31] Profile of patients with Kaposi's sarcoma in the era of highly active antiretroviral therapy
    Gallafent, JH
    Buskin, SE
    De Turk, PB
    Aboulafia, DM
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (06) : 1253 - 1260
  • [32] Kaposi's sarcoma associated with highly active antiretroviral therapy
    Crane, HM
    Deubner, H
    Huang, JC
    Swanson, PE
    Harrington, RD
    INTERNATIONAL JOURNAL OF STD & AIDS, 2005, 16 (08) : 583 - 583
  • [33] Effect of highly active antiretroviral therapy on survival among HIV-infected men with Kaposi sarcoma or non-Hodgkin lymphoma
    Tam, HK
    Zhang, ZF
    Jacobson, LP
    Margolick, JB
    Chmiel, JS
    Rinaldo, C
    Detels, R
    INTERNATIONAL JOURNAL OF CANCER, 2002, 98 (06) : 916 - 922
  • [34] Sclerosing Kaposi's sarcoma of the adrenal gland in an HIV-infected patient under antiretroviral therapy
    Castrejon, Natalia
    Nicolau, Carlos
    Gonzalez-Cordon, Ana
    Archilla, Ivan
    Sole, Manel
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2019, 38 : 123 - 125
  • [35] Long-term prognosis of HIV-infected patients with Kaposi sarcoma treated with pegylated liposomal doxorubicin
    Martin-Carbonero, L.
    Palacios, R.
    Valencia, E.
    Saballs, P.
    Sirera, G.
    Santos, I.
    Baldobi, F.
    Alegre, M.
    Goyenechea, A.
    Pedreira, J.
    Gonzalez del Castillo, J.
    Martinez-Lacasa, J.
    Ocampo, A.
    Alsina, M.
    Santos, J.
    Podzamczer, D.
    Gonzalez-Lahoz, J.
    CLINICAL INFECTIOUS DISEASES, 2008, 47 (03) : 410 - 417
  • [36] The prevalence and risk of immune restoration disease in HIV-infected patients treated with highly active antiretroviral therapy
    Jevtovic, D
    Salemovic, D
    Ranin, J
    Pesic, I
    Zerjav, S
    Djurkovic-Djakovic, O
    HIV MEDICINE, 2005, 6 (02) : 140 - 143
  • [37] Cardiac Steatosis and Left Ventricular Dysfunction in HIV-Infected Patients Treated With Highly Active Antiretroviral Therapy
    Nelson, Michael D.
    Szczepaniak, Lidia S.
    LaBounty, Troy M.
    Szczepaniak, Edward
    Li, Debiao
    Tighiouart, Mourad
    Li, Quanlin
    Dharmakumar, Rohan
    Sannes, Gregg
    Fan, Zhaoyang
    Yumul, Roya
    Hardy, W. David
    Conte, Antonio Hernandez
    JACC-CARDIOVASCULAR IMAGING, 2014, 7 (11) : 1175 - 1177
  • [38] The interaction between smoking status and highly active antiretroviral therapy (HAART) use on the risk of Kaposi’s sarcoma (KS) in a cohort of HIV-infected men
    H N Luu
    E S Amirian
    M E Scheurer
    British Journal of Cancer, 2013, 108 : 1173 - 1177
  • [39] The interaction between smoking status and highly active antiretroviral therapy (HAART) use on the risk of Kaposi's sarcoma (KS) in a cohort of HIV-infected men
    Luu, H. N.
    Amirian, E. S.
    Scheurer, M. E.
    BRITISH JOURNAL OF CANCER, 2013, 108 (05) : 1173 - 1177
  • [40] Incidence of pneumonia in HIV-infected patients in the highly active antiretroviral therapy era
    Velasco Arribas, Maria
    Satue Bartolome, Jose Angel
    Losa Garcia, Juan Emilio
    Espinosa Gimeno, Alfredo
    Delgado-Iribarren, Alberto
    Castilla Castellano, Virgilio
    MEDICINA CLINICA, 2007, 128 (04): : 130 - 132
12345